ReproCELL Incorporated (TYO:4978)

Market Cap	14.22B -21.8%
Revenue (ttm)	2.30B -18.7%
Net Income	-436.00M
EPS	-4.59
Shares Out	103.83M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	380,100
Open	137.00
Previous Close	137.00
Day's Range	135.00 - 138.00
52-Week Range	117.00 - 242.00
Beta	0.55
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About ReproCELL

ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, StemEdit gene edited iPSCs, mesenchymal stem cells (MSCs), and new immortalized cell lines and related reagents; and iPSC-...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2003
• Employees: 101
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4978

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 16, 2026

Data Sources Report a data error